Ingham Institute’s Revealed New Cancer Research Technology

admin Interviews

Professor Michael Barton OAM, Ingham Institute Research Director with Ingham Institute ambassador Lisa Wilkinson. Image source: Ingham Institute

Professor Michael Barton OAM, Ingham Institute Research Director with Ingham Institute ambassador Lisa Wilkinson.
Image source: Ingham Institute

The Ingham Institute for Applied Medical Research revealed its much-awaited MRI-Linac cancer research technology earlier this month at a special event in the institute’s high-tech, purpose built Research Bunker at Liverpool Hospital.

The new technology is set to improve the precision and accuracy of radiotherapy. Current radiotherapy practices are limited to account for changes that occur to the location and shape of tumours.

By combining an MRI with a Linac accelerator the Ingham Institute’s MRI-Linac system will enable a super-charged view of the tumour to ensure more precise and accurate treatment for cancer patients.

“Current cancer treatments don’t take into account changes that can occur to the location and shape of tumours, which move as a result of breathing, swallowing and other normal body changes” explained Professor Michael Barton OAM, Ingham Institute Research Director.

“The MRI-Linac will enable us to target the tumour with the radiation beam much more accurately in real-time, and have greater control over the radiation dose,” continues Professor Barton.

The exclusive preview of stage one of the MRI-Linac was well attended by Ingham Institute partners, sponsors, guests and Ingham Institute ambassador Lisa Wilkinson.

The Ingham Institute MRI-Linac team includes some of the best medical minds in the world including Chief Investigator Professor Paul Keall, from the University of Sydney and Senior MR Physicist Dr Gary Liney who was recruited from the UK.

Interview with Professor Paul Keall:

      1. Prof Keall - Prof Keall